A ground-breaking HealthTech co-founded by Spotify’s Daniel Ek has raised $700 million in Series C funding.
Ek founded Neko Health with Hjalmar Nilsonne to redefine how people understand and act on their health.
At the heart of Neko’s offering is the Neko Health Scan – a 60-minute, comprehensive, non-invasive and radiation-free health assessment that captures millions of health data points.
More than 350,000 people have joined the waitlist or registered for a Neko Health Scan, and more than 100,000 in the UK and Sweden have already experienced one. The firm has added clinics in Manchester and Birmingham, as well as multiple locations in London.
Priced at £299 in the UK and 2,750 SEK in Sweden, the scan uses proprietary sensors alongside blood analysis to assess skin health, including moles and marks; biomarkers to identify pre-diabetes risk; blood abnormalities; and risk factors linked to metabolic syndrome, stroke and heart attack.
Results are delivered on-site within minutes and discussed during an in-person consultation with a medical professional, providing members with personalised and actionable health findings.
In addition, body composition measures, captured in seconds during the scan, and clinician review of wearable data, is now live across all clinics – giving members an even more detailed picture of their health both in the moment and between visits. All Neko Health’s technology has been built in-house, including hardware, software and consumer experience.
Last month, Neko opened its latest clinic in Stockholm, built around the next generation of Neko-engineered medical devices, Derma-2, Echo-2, and Spectrum-2, each upgraded to capture a greater volume and higher fidelity of health signals across skin, heart, and circulation, with increased automation freeing up clinical staff to focus on member care.
The hardware will be rolled out across all Neko clinics in the next few months.
The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, with participation from existing investors Atomico, General Catalyst and Lakestar, alongside new backers including Liberty City Ventures, Positive Sum, and BDT & MSD.
As part of the round, David Ofer of O.G. Venture Partners will join the board of directors, subject to regulatory approval. The fundraise follows a $260m Series B in January 2025.
Bejul Somaia, global partner, Lightspeed Venture Partners, said: “Over the past 18 months, Neko Health has demonstrated remarkable innovation and growth, attacking one of the largest markets in the world with breakthrough technology, proven consumer demand, and a clear path to global scale.
“We believe this is one of the most important healthcare companies of our generation, and we’re proud to deepen our partnership as they continue to reimagine prevention.”
Eyal Ofer of O.G. Venture Partners said: “We’ve known Hjalmar, Daniel and the founding team at Neko Health for years and have deep respect for their vision to redefine health for more than just the privileged few, on a global scale. They execute at a level few can match.”
Valarian raises £37m to build UK sovereign AI infrastructure
The funding round also saw participation from Ari Emanuel, Claudia Schiffer and Sir Matthew Vaughn, Danny Meyer, Jimmy Iovine, Maria Sharapova, Mark Zuckerberg and Priscilla Chan, Thierry Henry, Tim Ferriss and will.i.am, joining existing investors including Alexis Ohanian from Seven Seven Six, Alex Tew and Michael Acton-Smith from Calm, Gary Vaynerchuk, Jessie Inchauspé, Katie Haun, Raj Shamani, Steven Bartlett, Zoë Saldaña and Marco Perego-Saldaña.
“For more than 20 years, I’ve tracked every metric imaginable to optimise health and performance,” said Ferriss, bestselling author of The 4-Hour Body, which introduced millions to data-driven personal health, including continuous glucose monitors, DEXA, and other technologies.
“It’s expensive, complicated, and fragmented. I’ve invested in Neko because they offer beautiful simplicity, and only simplicity scales: you get a high-definition map of your biology in less than 60 minutes, explained by an unhurried doctor, all in one location and for £299.
“No one else can do this. And believe me, as I’ve toured their R&D lab in Sweden: there’s a lot more coming.”
Co-founder Nilsonne previously co-founded and served as CEO of Watty, an energy data company which was acquired by Assa Abloy. He was raised in a family of doctors.
He said: “This funding is a strong vote of confidence in what we set out to do when we opened our first clinic three years ago: a completely new healthcare experience designed to keep people healthy, catch problems early and help prevent disease before it even starts.
“With this round, we’re taking that mission to the US for the first time, while continuing to invest in the research and technology that make prevention possible at scale.
“The clearest proof is in our members: the vast majority of our members return after their first scan, and when they do, their health markers move in the right direction.”